Wednesday, August 15, 2018
Company News: Page (1) of 1 - 08/10/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Longs Pharmacy Solutions Announces ACHC Accreditation for Longs Specialty Pharmacy and Avita Pharmacy
The ACHC designation demonstrates dedication to quality and excellence.
(August 10, 2018)

COLUMBIA, S.C., Aug. 10, 2018 /PRNewswire-PRWeb/ --áLongs Pharmacy Solutions announced today that two of its pharmacies have again achieved accreditation through Accreditation Commission for Health Care (ACHC) in specialty pharmacy. These two pharmacy locations are Longs Specialty Pharmacy located in Lexington, South Carolina, and Avita Pharmacy located in Baton Rouge, Louisiana.

Accreditation is a process through which healthcare organizations demonstrate compliance with national standards. Accreditation by ACHC reflects an organization's dedication and commitment to meeting standards that facilitate a higher level of performance and patient care.

ACHC is a non-profit organization that has stood as a symbol of quality and excellence since 1986. ACHC is ISO 9001:2015 certified and has CMS deeming authority for Home Health, Hospice and HMEPOS.

Christi Epps, CEO of Longs Pharmacy Solutions, commented, "We are committed to excellence company-wide. This renewed accreditation represents a renewed commitment to quality patient care."

Longs Pharmacy Solutions is a national pharmacy network, family of brands, and industry leader in specialty and retail pharmacy services and solutions. We are committed to excellence and are advocates for health, equity, and diversity. Longs Pharmacy Solutions promises more than just pharmacy careŚwe promise to be a dedicated partner for every person, provider, and community we serve. The Longs Pharmacy Solutions family of brands includes Longs Drugs, Longs Specialty Pharmacy, and Avita Pharmacy.


SOURCE Longs Pharmacy Solutions

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Science,Medical,Family,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease
  • Global Spinal Fusion Devices Market Expected to Reach USD 6.8 Billion By 2024: Zion Market Research

  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Pricing of Public Offering of Common Stock
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts
  • CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results
  • Citius Announces Closing of $10.0 Million Underwritten Offering Priced At-the-Market

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines